代谢障碍中的加勒-3:机制和治疗潜力
Qian Jiang1, Qijin Zhao1, Pingping Li1
1State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China; Diabetes Research Center of Chinese Academy of Medical Sciences, Beijing 100050, China; CAMS Key Laboratory of Molecular Mechanism and Target Discovery of Metabolic Disorder and Tumorigenesis, Beijing 100050, China.
Trends in molecular medicine
|December 17, 2024
概括
加勒-3 (Gal3) 在代谢疾病中升高,并驱动其进展. 这篇评论详细介绍了Gal3的细节.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 代谢疾病 代谢疾病
背景情况:
- 加勒-3 (Gal3) 是一种莱克,主要存在于免疫和炎症细胞中.
- 在肥胖,糖尿病和与代谢功能障碍相关的脂肪性肝病 (MASLD) 中观察到高的Gal3水平.
- 3在这些代谢条件的推进中发挥着重要作用.
研究的目的:
- 审查Gal3.3的结构,翻译后的修改和亚细胞局部依赖的功能.
- 阐明Gal3在各种细胞类型中的病理作用和分子机制.
- 讨论Gal3抑制剂和抗体的当前临床试验,并确定未来的研究方向.
主要方法:
- 文献综述侧重于Gal3的结构,功能和疾病相关性.
- 分析细胞局部化及其对Gal3生理和病理作用的影响.
- 关于Gal3向治疗药物的临床前和临床数据的摘要.
主要成果:
- 3的结构和翻译后的修改影响了它的功能.
- 亚细胞局部化 (细胞外与细胞内) 决定了不同的Gal3功能.
- 通过各种细胞机制,Gal3有助于代谢疾病的发病.
结论:
- 3是代谢疾病中的关键媒介,根据其位置具有不同的功能.
- 用抑制剂或抗体向Gal3显示出治疗前景.
- 需要进一步的研究,才能充分理解Gal3的复杂作用,并优化治疗策略.
相关概念视频
Overview of Carbohydrate Metabolism
724
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
724
Inborn Errors of Metabolism
127
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
127
Glucose Transporters
22.4K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.4K
Glucose Absorption Into the Small Intestine
31.3K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
31.3K
Glucagon-like Receptor Agonists
297
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
297
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K


